WHO lists anti-Covid Moderna vaccine for emergency use

Canada to receive 1.5 mln AstraZeneca doses from US next week

Photo credit: Pixabay / CC0 Public Domain

The World Health Organization said Friday it had listed the anti-COVID-19 Moderna vaccine for emergency use.

The listing process helps countries that are unable to assess the effectiveness of a vaccine themselves to gain access as quickly as possible, and enables the Covax vaccine sharing system and other partners to distribute it to poorer countries.

The US vaccine is the fifth stab to get on the WHO emergency list.

The U.S. Food and Drug Administration issued an emergency approval for the Moderna vaccine on December 18, 2020, and the European Medicines Agency issued a European Union-wide marketing authorization on January 6, 2021.

The WHO said in a statement that its Strategic Advisory Group of Experts on Immunization (SAGE) found the Moderna vaccine to be 94.1 percent effective.

The other emergency vaccines listed by WHO are Pfizer BioNTech; AstraZeneca; Serum Institute of India; and Janssen.

Moderna announced on Thursday that it would produce up to three billion doses of its vaccine by 2022 through new funding commitments to increase the supply of manufacturing facilities in Europe and the United States.

Follow the latest news on the Coronavirus (COVID-19) outbreak

© 2021 AFP

WHO lists anti-Covid Moderna vaccine for emergency (2021, April 30)
accessed on May 1, 2021
from https://medicalxpress.com/news/2021-04-anti-covid-moderna-vaccine-emergency.html

This document is subject to copyright. Apart from fair treatment for the purpose of private study or research, no
Part may be reproduced without written permission. The content is provided for informational purposes only.


Please enter your comment!
Please enter your name here